[18F]FET

O-(2-[18F]fluoroethyl)-L-tyrosine · Telix Pharmaceuticals (Innovations) Pty Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for [18F]FET, covering 2017-07-21 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes